TransMedics GroupHAM:8T8 -9.99%69 Interest Coverage is 1.85 as of Mar. 2026, which is 65% below its 10-year median of 5.24. GuruFocus rates HAM:8T8 with a GF Score™ of 69/100 and a GF Value™ of €162.08. The stock has 9 warning signs investors should review. Among 466 Medical Devices & Instruments companies, TransMedics Group ranks worse than 74.46% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. TransMedics Group's
Operating Income
for the
three
months ended in Mar. 2026 was €11.5 Mil. TransMedics Group's Interest Expense for the
three
months ended in Mar. 2026 was €-6.2 Mil.
TransMedics Group's interest coverage for the quarter that ended in Mar. 2026 was 1.85.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for TransMedics Group's Interest Coverage or its related term are showing as below:
HAM:8T8'
s Interest Coverage Range Over the Past 10 Years
Min: 2.6 Med: 5.24 Max: 7.88
Current: 5.4
HAM:8T8's Interest Coverage is ranked worse than 74.46% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs HAM:8T8: 5.40
TransMedics Group (HAM:8T8) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
TransMedics Group Interest Coverage Related Terms
TransMedics Group Interest Coverage Historical Data
* Premium members only.
The historical data trend for TransMedics Group's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
HAM:8T8 vs AXGN, BFLY, ESTA: Interest Coverage Comparison
For the Medical Devices subindustry, TransMedics Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (HAM:8T8) has a Interest Coverage of 1.85 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on TransMedics Group and its competitors. This is 65% below median its historical median of 5.24. Over the past decade, TransMedics Group's Interest Coverage has ranged from 2.60 to 7.88. According to the industry distribution chart, TransMedics Group ranks #347 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 74.5%.
Is TransMedics Group's Interest Coverage too high?
TransMedics Group's current Interest Coverage of 1.85 is 65% below median its 10-year median of 5.24. Over the past 10 years, this metric has ranged from a low of 2.60 to a high of 7.88. The Medical Devices & Instruments industry median Interest Coverage is 15.88. TransMedics Group's value of 1.85 is 88.3% below this industry median. Based on the distribution chart, TransMedics Group ranks #347 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, TransMedics Group has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Interest Coverage compare to AXGN and BFLY?
According to the Medical Devices & Instruments industry distribution chart, TransMedics Group ranks #347 out of 466 companies for Interest Coverage. This places TransMedics Group in the lower half of its industry. The industry median Interest Coverage is 15.88. TransMedics Group's value of 1.85 is 88.3% below this benchmark. Historically, TransMedics Group's own Interest Coverage has ranged from 2.60 to 7.88 over the past decade. While the company's 10-year median is 5.24 vs. the industry median of 15.88, TransMedics Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TransMedics Group's current Interest Coverage of 1.85 is 88.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on TransMedics Group and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransMedics Group's current Interest Coverage is 1.85, which is 65% below median its own 10-year median of 5.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
TransMedics Group (HAM:8T8) has a current Interest Coverage of 1.85. The stock's GF Value™ is €162.08, compared to a current price of €60.02 — trading 63% below its estimated fair value. The current Interest Coverage is 1.85, which is 65% below median its 10-year median of 5.24 and 88.3% below the Medical Devices & Instruments industry median of 15.88. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For TransMedics Group (HAM:8T8), the current Interest Coverage is 1.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TransMedics Group (HAM:8T8) Overvalued in 2026?
Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued.
The current stock price of €60.02 is trading 63% below its estimated GF Value™ of €162.08.
Key valuation signals for HAM:8T8:
Interest Coverage: 1.85 (65% below median its 10-year median of 5.24)
GF Value™: €162.08 vs. price of €60.02 (63% below fair value)
Industry Position: 88.3% below the Medical Devices & Instruments median (#347 of 466)
No single metric tells the full story. See the HAM:8T8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score
Get the complete analysis for HAM:8T8
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:8T8 has been successfully added to your 
